Zentalis Pharmaceuticalsllc Stock In The News
| ZNTL Stock | USD 12.54 0.17 1.34% |
The tone or emotional content of news articles related to Zentalis PharmaceuticalsL can affect its prices. Positive news sentiment can lead to an increase in demand for Zentalis PharmaceuticalsL's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Zentalis PharmaceuticalsL's news coverage and content from conventional and social sources shows investors' bearish mood towards Zentalis PharmaceuticalsLlc. The specific impact of Zentalis PharmaceuticalsL news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Zentalis PharmaceuticalsL's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Zentalis PharmaceuticalsL headlines in addition to utilizing other, more conventional financial analysis modules. Check out Zentalis PharmaceuticalsL Backtesting and Zentalis PharmaceuticalsL Hype Analysis.
Zentalis |
Zentalis PharmaceuticalsL Today Top News and Investor Outlook
Zentalis PharmaceuticalsLlc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Zentalis and other traded companies coverage. We help investors stay connected with Zentalis headlines for the 19th of April to make an informed investment decision based on correlating the impacts of news items on Zentalis Stock performance. Please note that trading solely based on the Zentalis PharmaceuticalsLlc hype is not for everyone as timely availability and quick action are needed to avoid losses.Zentalis PharmaceuticalsL stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Zentalis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Zentalis PharmaceuticalsL that are available to investors today. That information is available publicly through Zentalis media outlets and privately through word of mouth or via Zentalis internal channels. However, regardless of the origin, that massive amount of Zentalis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zentalis PharmaceuticalsL news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zentalis PharmaceuticalsL relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zentalis PharmaceuticalsL's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zentalis PharmaceuticalsL alpha.
Zentalis Largest EPS Surprises
Earnings surprises can significantly impact Zentalis PharmaceuticalsL's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-11-09 | 2020-09-30 | -0.81 | -0.91 | -0.1 | 12 | ||
2023-11-06 | 2023-09-30 | -0.91 | -0.79 | 0.12 | 13 | ||
2023-03-01 | 2022-12-31 | -1.06 | -0.92 | 0.14 | 13 | ||
2022-08-09 | 2022-06-30 | -1.19 | -1.34 | -0.15 | 12 | ||
2021-08-12 | 2021-06-30 | -1.17 | -1.34 | -0.17 | 14 | ||
2022-11-09 | 2022-09-30 | -1.17 | -0.96 | 0.21 | 17 |
Zentalis PharmaceuticalsL Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Zentalis PharmaceuticalsL Stock. The global stock market is bullish. About 66% of major world exchanges and indexes are currently up. See today's market update for more information.
11th of April 2024
Disposition of tradable shares by Vultaggio Vincent of Zentalis PharmaceuticalsL subject t... at investing.com
5th of April 2024
Disposition of 25000 shares by Vultaggio Vincent of Zentalis PharmaceuticalsL at 11.69 sub... at MacroaxisInsider
2nd of April 2024
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor A... at finance.yahoo.com
1st of March 2024
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635 at globenewswire.com
29th of February 2024
We Think Zentalis Pharmaceuticals Can Afford To Drive Business Growth at simplywall.st
28th of February 2024
Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. Could Surge 136.44 percent Read ... at zacks.com
27th of February 2024
Zentalis Pharmaceuticals GAAP EPS of -4.47 beats by 0.06 at seekingalpha.com
22nd of February 2024
Zentalis Pharmaceuticals Trading 4.2 percent Higher at thelincolnianonline.com
8th of February 2024
What Makes Zentalis Pharmaceuticals, Inc. a New Buy Stock at zacks.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zentalis PharmaceuticalsL in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zentalis PharmaceuticalsL's short interest history, or implied volatility extrapolated from Zentalis PharmaceuticalsL options trading.
Check out Zentalis PharmaceuticalsL Backtesting and Zentalis PharmaceuticalsL Hype Analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.